{"id":"W2205469793","doi":"10.1186/s40425-015-0093-x","title":"A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial","year":2015,"lang":"en","type":"review","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Medicine; Cancer vaccine; Clinical trial; Adjuvant; Cancer; Oncology; Phase (matter); Internal medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02008175,0.0009498463,0.002379915,0.002763219,0.0001940018,0.002084989,0.001159265,0.001065729,0.003949984],"category_scores_gemma":[0.0244396,0.0003791195,0.002200405,0.0028883,0.0005628145,0.001736923,0.0007577571,0.001558606,0.0009947086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001559759,"about_ca_system_score_gemma":0.003066458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004168498,"about_ca_topic_score_gemma":0.0008969281,"domain_scores_codex":[0.9923544,0.003410896,0.001230574,0.000700322,0.002063701,0.0002401737],"domain_scores_gemma":[0.9784728,0.01280111,0.004381433,0.000713161,0.003271123,0.0003603213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002013578,0.0001854633,0.002132188,0.04317598,0.002019157,0.00009451425,0.0001067926,0.001631988,0.005643518,0.005667298,0.01501045,0.9223192],"study_design_scores_gemma":[0.001637397,0.00740151,0.03028568,0.05076384,0.009351715,0.002059111,0.0002993614,0.00274365,0.01413424,0.01745063,0.8636791,0.0001937838],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005785026,0.9704819,0.01091453,0.002063735,0.000686529,0.001573831,0.002164143,0.0001088716,0.006221454],"genre_scores_gemma":[0.07345257,0.8777968,0.02963062,0.005029338,0.001164009,0.004279455,0.003483155,0.0001475007,0.005016592],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02008175,"threshold_uncertainty_score":0.1062037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1487543164012257,"score_gpt":0.5064022692511208,"score_spread":0.357647952849895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}